Navigation Links
Barr Announces Approval of Generic Camptosar(R) Injection, 20 mg/mL
Date:11/3/2008

mpanies (such as PLIVA d.d.) and products we acquire; fluctuations in operating results, including the effects on such results from spending for research and development, sales and marketing activities and patent challenge activities; the inherent uncertainty associated with financial projections; our expansion into international markets through our PLIVA acquisition, and the resulting currency, governmental, regulatory and other risks involved with international operations; our ability to service our significantly increased debt obligations as a result of the PLIVA acquisition; changes in generally accepted accounting principles; the reactions of the Company's customers and suppliers to the merger; and diversion of management time on merger-related issues. These and other applicable risks, cautionary statements and factors that could cause actual results to differ from the Company's forward-looking statements are included in the Company's filings with the U.S. Securities and Exchange Commission ("SEC"), specifically as described in the Company's annual report on Form 10-K for the fiscal year ended December 31, 2007. The Company undertakes no obligation to update or revise any forward-looking statements to reflect subsequent events or circumstances.

Important Legal Information

In connection with the proposed merger, Teva has filed a registration statement on Form F-4 containing a proxy statement/prospectus for shareholders of the Company with the SEC, and the Company and Teva may be filing other documents regarding the proposed transaction with the SEC as well. Before making any voting or investment decision, investors are urged to read the proxy statement/prospectus regarding the proposed transaction, as well as the other documents referred to in the proxy statement/prospectus carefully in their entirety when they become available because they will contain important information about the proposed transaction. The definitive proxy statement/prospectus
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Pregis Announces Investor Conference Call to Review 2008 Third Quarter Financial Results
2. BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome
3. Insulet Announces Sponsorship of International Diabetes Federations World Diabetes Day Campaign
4. SXC Health Solutions announces PBM services agreement with Health Plan of San Mateo
5. Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics
6. China-Biotics, Inc. Announces Conference Call to Discuss Second Quarter 2009 Financial Results
7. Hooper Holmes Announces Third Quarter Earnings Release Date and Conference Call Information
8. Chindex International, Inc. Announces Preliminary Second Quarter Results and Improved Revenue Outlook for Fiscal 2009
9. Chindex International, Inc. Announces Appearances at Additional November Conferences
10. JZZ Technologies, Inc. Announces 3rd Quarter Results Date
11. Konica Minolta Sensing Americas Announces the Launch of the CM-SA Skin Analysis Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... (PRWEB) October 20, 2014 It’s hard to ... many orphans and vulnerable children around the world, it’s a ... some people, many children are forced to walk barefoot on ... their families or play with their friends. , Buckner ... with Air1 Radio in October to encourage support ...
(Date:10/20/2014)... USA (PRWEB) October 20, 2014 Do ... track interventions? Here comes a wonderful app Metassessor for ... app development company helped its client “Intervention Development ... efficiently. The app is designed for iOS 4.3 or ... touch. This app is optimized for iPhone 5. It ...
(Date:10/19/2014)... 20, 2014 Recently, BambooIndustry.com, one of ... its new range of bamboo deckings . Moreover, ... natural items; they are now available at deeply discounted ... it is hard to overstate the significance of online ... to online services. The company’s workers are striving to ...
(Date:10/19/2014)... working in the garment industry for decades, LunaDress’ dress specialists ... one of the company’s top designers, many ladies like prom ... add beauty to them. Chiffon floor length outfits are also ... selection of 2014 long prom dresses. , As a ... in over 20 popular designs. The company intends to meet ...
(Date:10/19/2014)... SweetDressy.com, a professional company of women’s dresses and ... evening dresses . All the company’s old and ... discount is up to 66 percent off. , ... fashion field. Its dress specialists are striving to make ... of the world. All the company’s items are unique, ...
Breaking Medicine News(10 mins):Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2Health News:Promotion For Beautiful Long Evening Dresses Launched By SweetDressy.com 2
... At NYU Langone Medical Center the focus on quality, ... stroke initiatives but measureable, quantifiable and concrete. Patients ... to world-class care and operational transparency in the Department ... Report," which is now available online as well as ...
... the strongest known risk factors for spontaneous or unexpected preterm ... of pregnancy, most often without a known cause is ... would like to avoid this scenario in their second pregnancy, ... the best strategy. A new study reported at the Society ...
... PHILADELPHIACurcumin, an active component of the Indian curry spice ... prostate cancer patients on androgen deprivation therapy (ADT), a ... suggests. Reporting in a recent issue ... , a Professor of Cancer Biology, Urology and Radiation ...
... HealthDay Reporter , THURSDAY, Feb. 9 (HealthDay News) ... marijuana nearly doubles a driver,s risk of having an accident, ... especially high for fatal crashes, and the risk is only ... Canadian researchers say. "On the whole, alcohol increases the ...
... New research presented at the 2012 Annual Meeting of ... more than 4.5 million Americans are living with a ... surgeries has more than doubled over the past decade, ... to be the primary reason for TKR., Investigators used ...
... In a study to be presented today at ... Meeting , in Dallas, Texas, researchers will report that ... the lateral ventricles of neonatal rats with birth-related brain ... survive and migrate in the recipient,s brain. The ...
Cached Medicine News:Health News:Orthopaedic surgery report provides transparency on patient safety, quality initiatives 2Health News:To avoid early labor and delivery, weight and diet changes not the answer 2Health News:Curry spice component may help slow prostate tumor growth 2Health News:Pot Use Could Double Risk of Car Crash, Research Shows 2Health News:Pot Use Could Double Risk of Car Crash, Research Shows 3Health News:Pot Use Could Double Risk of Car Crash, Research Shows 4Health News:4.5 million Americans living with total knee replacement 2Health News:Neurologic improvement detected in rats receiving stem cell transplant 2
(Date:10/20/2014)... DIEGO , Oct. 20, 2014 ... industry leader in bioactive lipid-targeted therapeutics, received official notification ... has been granted another key patent supporting its ... newly issued patent, European patent No. 2087002, claims ... substance in Lpath,s two lead compounds, iSONEP and ...
(Date:10/20/2014)... 2014 Norgine B.V. today announced ... volume bowel preparation, NER1006, presented at the 79 th ... Gastroenterology (ACG), Philadelphia, PA , has ... and co-primary endpoint of cleansing success. The study demonstrated ... ® in screening colonoscopy patients. [1] ...
(Date:10/19/2014)... Oct. 20, 2014 CTI BioPharma Corp. (CTI) ... report its third quarter 2014 financial results on Wednesday, ... financial markets. Following the announcement, members of the management ... the results and provide a general corporate update at ... event can be obtained as follows: Wednesday, ...
Breaking Medicine Technology:Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 2Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 4Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 2
... Nov. 16 Announced on November 06, 2009 by Mr. ... Inc., and the Board of MEGGLE Group of Wasserburg, Germany, ... Mr. Christian Sedlatschek, CFO, the companies are entering a long-term ... States. , DAVISCO Foods is an international cheese and food ...
... , ACPCN Joins Congressional Leaders to Introduce Legislation ... Association of Community Pharmacists Congressional Network (ACPCN) will join ... Real Medication Access Cost Savings Act." The bill ... dependence on pharmacy benefit management (PBM) companies for medications. ...
Cached Medicine Technology:DAVISCO Foods International, Inc. and MEGGLE Group Announce a Joint Venture for the Production of Pharmaceutical Lactose. 2Pharmacists Work with Congress to Address PBM Abuses 2
... The CA-1000 counts a Petri dish ... on the optical characteristics of the colonies ... The CA-1000 is equipped with three types ... are lighter or darker than the agar ...
Basic critical care testing. Measures pH, pCO2, and pO2 from 85 L whole-blood sample....
... Rapidpoint 400 is a sophisticated whole blood ... point-of-care testing while also satisfying the stringent ... multiple-use measurement cartridge contains all of the ... long-lasting cartridge includes the sampling unit, all ...
The AVL Omni modular system is a complete blood gas solution designed for high-volume critical care use, with customized test combinations, minimum intervention and flexibility....
Medicine Products: